Mighty Oak Medical, Inc., Medacta USA, Inc., and Medacta International SA have resolved a patent dispute involving patient-specific pedicle screw guides.
Mighty Oak Medical and Medacta Settle Patent Dispute

Mighty Oak initially filed its complaint for patent infringement in 2022.
The initial complaint involved the following patents Mighty Oak owns by assignment:
- S. Patent No. 8,758,357 titled “Patient Matching Surgical Guide and Method for Using the Same”;
- S. Patent No. 8,870,889 titled “Patient Matching Surgical Guide and Method for Using the Same”;
- S. Patent No. 9,198,678 titled “Patient-Matched Apparatus and Methods for Performing Surgical Procedures”;
- S. Patent No. 9,642,633 titled “Patient-Matched Apparatus and Methods for Performing Surgical Procedures”; and
- S. Patent No. 9,987,024 titled “Patient-Matched Apparatus and Methods for Performing Surgical Procedures.”
Mighty Oak Medical alleged that Medacta included concepts from the patents in its MySpine products. This includes the MySpine Standard device which received FDA clearance in 2014.
Mighty Oak Medical and Medacta have recently entered into a settlement, release, and license agreement to resolve the dispute. The parties have requested that the court order that all claims asserted be dismissed with prejudice.
According to Medacta’s press release, under the terms of the agreement, “Medacta will receive a non-exclusive license to Mighty Oak’s patents related to patient-specific pedicle screw guides for use in adult spinal surgeries.” Additionally, “Globally, Medacta has agreed to sell its MySpine Guides for use exclusively with Medacta pedicle screws through 2031.”
Mighty Oak VP of Sales and Marketing Nick Byrne commented, “We are pleased to have resolved the ongoing litigation with Medacta and are excited to re-focus all internal resources on developing the next generation of presurgical planning and patient-specific solutions to enhance patient care.”
Mighty Oak is a medical device development company focused on spinal surgery solutions. Medical Oak Chief Medical Officer George Frey, M.D. is a spinal surgeon and inventor. He is the named inventor on the patents involved in the litigation. The subject patents relate to Mighty Oak’s FIREFLY® navigation guides for use in spinal surgeries.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.